You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for New Drug Application (NDA): 021287


✉ Email this page to a colleague

« Back to Dashboard


NDA 021287 describes UROXATRAL, which is a drug marketed by Concordia and is included in one NDA. It is available from one supplier. Additional details are available on the UROXATRAL profile page.

The generic ingredient in UROXATRAL is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.
Summary for 021287
Tradename:UROXATRAL
Applicant:Concordia
Ingredient:alfuzosin hydrochloride
Patents:0
Pharmacology for NDA: 021287
Mechanism of ActionAdrenergic alpha-Antagonists
Suppliers and Packaging for NDA: 021287
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287 NDA Concordia Pharmaceuticals Inc. 59212-200 59212-200-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10)
UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287 NDA Concordia Pharmaceuticals Inc. 59212-200 59212-200-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Jun 12, 2003TE:ABRLD:Yes

Expired US Patents for NDA 021287

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 ⤷  Sign Up ⤷  Sign Up
Concordia UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.